Conditions: Diabetes Diabetes Mellitus, Type 2
Allocation: NON_RANDOMIZED | Intervention model: SINGLE_GROUP
Enrollment: 293
Healthy volunteers: no

Brief summary:
This trial is conducted in Asia. This single arm trial aims to evaluate the blood glucose control with twice daily biphasic insulin aspart 30 in combination with metformin in Chinese subjects with type 2 diabetes inadequately controlled with once or twice daily basal insulin.

Detailed description:

Arms:
arm 1: Individual adjusted dose of biphasic insulin aspart 30 administered before breakfast and dinner in combination with metformin 1000-2000mg, up to three times daily

Interventions: intervention 1: biphasic insulin aspart 30 intervention 2: metformin
Intervention descriptions: intervention 1: Subcutaneous (under the skin) injection, twice daily intervention 2: Tablets, 1000 - 2000 mg daily

Protocol document: